- Home
- BQ vs AZTR Comparison
BQ vs AZTR Comparison
Compare BQ & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- AZTR
- Stock Information
- Founded
- BQ 2008
- AZTR 2014
- Country
- BQ China
- AZTR United States
- Employees
- BQ N/A
- AZTR N/A
- Industry
- BQ Other Specialty Stores
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- AZTR Health Care
- Exchange
- BQ Nasdaq
- AZTR Nasdaq
- Market Cap
- BQ 3.1M
- AZTR 3.2M
- IPO Year
- BQ 2020
- AZTR 2023
- Fundamental
- Price
- BQ $0.30
- AZTR $0.25
- Analyst Decision
- BQ
- AZTR
- Analyst Count
- BQ 0
- AZTR 0
- Target Price
- BQ N/A
- AZTR N/A
- AVG Volume (30 Days)
- BQ 220.5K
- AZTR 3.0M
- Earning Date
- BQ 01-28-2025
- AZTR 03-14-2025
- Dividend Yield
- BQ N/A
- AZTR N/A
- EPS Growth
- BQ N/A
- AZTR N/A
- EPS
- BQ N/A
- AZTR N/A
- Revenue
- BQ $81,208,354.00
- AZTR $97,500.00
- Revenue This Year
- BQ N/A
- AZTR N/A
- Revenue Next Year
- BQ N/A
- AZTR N/A
- P/E Ratio
- BQ N/A
- AZTR N/A
- Revenue Growth
- BQ N/A
- AZTR N/A
- 52 Week Low
- BQ $0.22
- AZTR $0.24
- 52 Week High
- BQ $0.74
- AZTR $68.40
- Technical
- Relative Strength Index (RSI)
- BQ 40.81
- AZTR 36.62
- Support Level
- BQ $0.27
- AZTR $0.24
- Resistance Level
- BQ $0.41
- AZTR $0.65
- Average True Range (ATR)
- BQ 0.04
- AZTR 0.06
- MACD
- BQ -0.00
- AZTR -0.02
- Stochastic Oscillator
- BQ 24.43
- AZTR 1.71
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.